Walleye Capital LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,344,062
+283.8%
160,773
+1040.2%
0.00%
+300.0%
Q2 2023$350,244
+37.8%
14,100
-16.6%
0.00%
-75.0%
Q1 2023$254,176
-69.8%
16,900
-91.5%
0.00%
-82.6%
Q2 2022$842,000
+419.8%
198,233
+1098.5%
0.02%
-36.1%
Q1 2020$162,000
-52.1%
16,540
-45.6%
0.04%
+63.6%
Q4 2019$338,00030,4000.02%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders